Physician profile
Rejimol Abraham
NPI 1487213997
$2,523.93
in general payments reported to CMS, 2019-2025
17 companies · $2,142 in 2025
The $2,142 reported for 2025 was more than what 94% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $89.83 · 2024: $293 · 2025: $2,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,523.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noctrix Health, INC. | $568.23 | 2025 | Nidra |
| Abbvie INC. | $555.59 | 2023-2025 | Botox |
| Acadia Pharmaceuticals INC | $308.13 | 2024-2025 | Nuplazid |
| Merz Pharmaceuticals, LLC | $284.49 | 2024-2025 | Xeomin, Inbrija |
| Neurocrine Biosciences, INC. | $243.04 | 2024-2025 | Ingrezza |
| Amneal Pharmaceuticals LLC | $124.91 | 2024-2025 | Crexont, Ongentys |
| Csl Behring | $75.17 | 2023-2024 | Hizentra |
| Teva Pharmaceuticals USA, INC. | $58.22 | 2025 | Austedo Xr |
| Azurity Pharmaceuticals, INC. | $49.62 | 2024-2025 | Horizant, Edarbi |
| Kyowa Kirin, INC. | $47.85 | 2024-2025 | Nourianz |
| Biogen, INC. | $45.31 | 2025 | Skyclarys, Vumerity, Tysabri |
| Ipsen Biopharmaceuticals, INC | $33.22 | 2025 | Dysport |
| Eisai INC. | $30.26 | 2025 | |
| Cala Health, INC. | $29.30 | 2025 | Cala Kiq |
| Grifols USA, LLC | $28.45 | 2023-2025 | Gamunex-C |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $23.63 | 2023 | Nuedexta |
| Argenx US, INC. | $18.51 | 2023 | Vyvgart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rejimol Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.